Brief: ModivCare Q2 Adjusted EPS USD 1.47 Vs. IBES Estimate USD 1.62
03/08/2023 21:05
Aug 03 (Reuters) - ModivCare Q2 adjusted EBITDA USD 52.4 million. * Q2 net income USD -190.9 million * Q2 revenue USD 699.1 million vs. IBES estimate USD 653.9 million * Q2 adjusted net income USD 20.8 million * Q2 operating income USD -175.8 million
Recent news on ModivCare
See all newsBrief: Modivcare Completes Financial Restructuring
Modivcare plunges as Nasdaq to delist stock amid bankruptcy filing
Brief: Modivcare Receives Nasdaq Delisting Notice Following Chapter 11 Filing
U.S. STOCKS ON THE MOVE-Energy Fuels, Dynavax Technologies, Oklo
U.S. STOCKS ON THE MOVE-Yatsen, International Paper, GE Vernova